secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001193125-23-138306
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health names Ines Dahne-Steuber COO, promotes Darya Chudova to CTO
---------------------------------------------------------------------------

- Ines Dahne-Steuber appointed COO effective May 3, 2023; previously senior exec at Fresenius Medical Care.
- Compensation: $490k base salary, 50% target bonus, ~$2M in RSUs and ~$2M in stock options (four-year vesting).
- Signing bonus of $50k and relocation allowance up to $50k, subject to 12-month clawback.
- Darya Chudova promoted to CTO; led development of Shield blood-based colorectal cancer screening technology.
- Both appointments effective May 2023, aiming to scale global operations and support product launches.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523138306/0001193125-23-138306-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523138306/d452070d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-138306

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer